NCH1425 is a patient-derived IDH wildtype glioblastoma neurosphere cell line established from a primary WHO grade IV tumour obtained from a 74 year old female patient. The tumour has been classified as mesenchymal subtype (RTKII), reported as MGMT promoter positive, and BRAF negative. Cells grow as free floating neurospheres under serum-free conditions.
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.